CA

Catena Biosciences

YC S21 ↗

San Francisco, US · Founded 2020 · 7 employees · 7 known investors

catenabiosciences.com ↗

Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors. The company's technology enables therapeutic structures that deliver dual payloads to cancer targets.

Founders & leadership· Y Combinator alumni (S21)

ML

Marco LobbainFounder

MF

Matthew FrancisinFounder

Investors · 7

CI

Civilization Ventures Management, LlcTiburon · $1M – $10M

IA

Iaso VenturesCambridge

Y

Y CombinatorSan Francisco · $500K

AX

Axial VCreportedSan Francisco · $100K – $5M

LO

LongeVCreportedWashington D.C.

MB

MBX CapitalreportedClaymont · $250K – $2.5M

SO

Social Impact CapitalreportedNew York · $100K – $1.5M